True, evidence looks more like this:
Two well-done meta-analyses of statins for primary prevention showed no mortality benefit. After the exclusion of four trials with serious risks of bias, the relative risk of cardiovascular events associated with statins was 0.99 (95% confidence interval, 0.90 to 1.08).2,3